Matthieu Rosenberg, « La molécule du Tamiflu plus facile à produire », Bulletins Electroniques, Ambassade de France au Japon / ADIT, vol. Japon, no 396/BIO/2234, (lire en ligne).
cdc.gov
(en) Calatayud L, Lackenby A, Reynolds A, McMenamin J, Phin NF, Zambon MC, et al.Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009–2010. Emerg Infect Dis. 2011 Oct; Lire l'article (en anglais)[PDF].
(en)Centers for Disease Control and Prevention. Updated interim recommendationsfor the use of antiviral medications in the treatment and prevention of influenza for the 2009–2010 season [cited 2010 Dec 18].
(en) CDC, M.F. Ducatez et al.Vaccination campaigns and public health response should focus on high-risk groups. - Multiple Reassortment between Pandemic (H1N1) 2009 and Endemic Influenza Viruses in Pigs, United StatesRésumé.
(en) Maki Kiso DVM et al. ; Resistant influenza A viruses in children treated with oseltamivir: descriptive study; DOI10.1016/S0140-6736(04)16934-1, The Lancet, vol. 364, no 9436, p. 759-765, 2004-08-28 (Résumé).
(en) Kongkathip B, Akkarasamiyo S et Kongkathip N, « A new and efficient asymmetric synthesis of oseltamivir phosphate (Tamiflu) from d-glucose » Tetrahedron, 2015;71(16), 2393-2399 (résumé).
semanticscholar.org
pdfs.semanticscholar.org
(en) Josef D. Järhult1 et al., « Environmental Levels of the Antiviral Oseltamivir Induce Development of Resistance Mutation H274Y in Influenza A/H1N1 Virus in Mallards », PLOS One, vol. 6, no 9, (lire en ligne).
(en) Maki Kiso DVM et al. ; Resistant influenza A viruses in children treated with oseltamivir: descriptive study; DOI10.1016/S0140-6736(04)16934-1, The Lancet, vol. 364, no 9436, p. 759-765, 2004-08-28 (Résumé).
(en) Strong M, Burrows J, Stedman E, Redgrave P. Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom. Euro Surveill(en) 2010;15:pii:19565.
